Z-0093-2017 Class II Terminated
FDA device recall Z-0093-2017 was initiated by Tearscience, Inc on Sep 13, 2016 and is designated Class II. Reason for recall: Complaints related to an error condition occurring during patient treatment where the FipiFlow System automatically stopped treatment after detecting a problem with the Activator. The recall status is terminated (terminated Feb 9, 2017). Affected quantity: 1,200 Activators (120 boxes of 10 units).
Recall details
- Product Type
- Devices
- Report Date
- Oct 26, 2016
- Initiation Date
- Sep 13, 2016
- Termination Date
- Feb 9, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,200 Activators (120 boxes of 10 units)
Product description
Reason for recall
Distribution pattern
US Distribution including states of: AK, AR, CA, CO, FL, GA, ID, IL, IN, LA, MD, MA, MN, MO, NV, NM, NY, NC, OH, OK, OR, PA, SC, TN, TX, VA , WA, WI and Puerto Rico.
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0093-2017
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Tearscience, Inc? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.